About HospiraNews & MediaInvestor RelationsIn the Community
Home




Technical Resources

  • OptiQ® Technical Specifications

Q2™ & Q2™ Plus CCO/SO2 Monitoring Systems:

  • Provide rapid response to changes in cardiac output
  • Eliminate the need for bolus cardiac output injections
  • Exclusive 3-wavelength technology provides reliable SvO2 measurements without need for laboratory updates of hemoglobin or hematocrit
  • Quality Signal Indicator (QSI) communicates the strength of the CCO output signal
  • Standard interactive screens are menu driven
  • User selected signal processing modes provide flexibility
  • Large color screen clearly displays data

The Q2 Plus SO2/CCO monitor provides continuous measurement of cardiac output and blood oxyhemoglobin saturation levels. When used in conjunction with the OptiQ catheter, this system can provide information that may be valuable in assessing and managing the hemodynamic status of critically ill patients. Hospira's exclusive CCO algorithm provides rapid response to changes in cardiac output. The exclusive 3-wavelength system for reflectance spectrophotometry provides accurate SO2 measurements independent of varying hemoglobin levels. This eliminates the need for laboratory updates of hemoglobin and hematocrit. A large color screen and enhanced user interface allow for clear display and input of data.